Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P FORTINA

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
European Journal of Human Genetics : EJHG|October 22, 1998
Applications of emerging technologies to the study of human geneticsP Fortina
Minerva Medica|March 19, 2010
Therapy and prophylaxis of acute anterior poliomyelitisP FORTINA
Krankenpflege. Soins Infirmiers|April 1, 1984
[Public health. Conceived by the ones, realized by the others: home attendants of sick children]P Fortina
Minerva Medica|March 19, 2010
Peritonsillar abscess and diphtheriaP FORTINA, M RAPELLINI
Clinical Chemistry|July 27, 2001
Microarray technology and applications: an all-language literature survey including books and patentsL J Kricka, P Fortina
Current Opinion in Neurology|March 31, 1999
Vestibular and hearing loss in genetic and metabolic disordersP Gasparini, X Estivill, P Fortina
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2001
Analysis of short tandem repeat markers by capillary array electrophoresisE S Mansfield, R B Wilson, P Fortina
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|October 2, 2001
Microarray-based genetic analyses for studying susceptibility to arterial and venous thrombotic disordersE S Pollak, L Feng, H Ahadian, et al.
Acta Haematologica|January 1, 1980
Correlation between transfusion requirement, blood volume and haemoglobin level in homozygous beta-thalassaemiaV Gabutti, A Piga, P Fortina, et al.
Thrombosis and Haemostasis|July 15, 2000
In the presence of other inherited or acquired high-risk situations, the FV Cambridge mutation may be an additional thrombophilic risk factor, through its effect on APC sensitivityR Santacroce, A Bossone, V Brancaccio, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Human Genetics : EJHG|October 22, 1998
Applications of emerging technologies to the study of human geneticsP Fortina
Minerva Medica|March 19, 2010
Therapy and prophylaxis of acute anterior poliomyelitisP FORTINA
Krankenpflege. Soins Infirmiers|April 1, 1984
[Public health. Conceived by the ones, realized by the others: home attendants of sick children]P Fortina
Minerva Medica|March 19, 2010
Peritonsillar abscess and diphtheriaP FORTINA, M RAPELLINI
Clinical Chemistry|July 27, 2001
Microarray technology and applications: an all-language literature survey including books and patentsL J Kricka, P Fortina
Current Opinion in Neurology|March 31, 1999
Vestibular and hearing loss in genetic and metabolic disordersP Gasparini, X Estivill, P Fortina
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2001
Analysis of short tandem repeat markers by capillary array electrophoresisE S Mansfield, R B Wilson, P Fortina
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|October 2, 2001
Microarray-based genetic analyses for studying susceptibility to arterial and venous thrombotic disordersE S Pollak, L Feng, H Ahadian, et al.
Acta Haematologica|January 1, 1980
Correlation between transfusion requirement, blood volume and haemoglobin level in homozygous beta-thalassaemiaV Gabutti, A Piga, P Fortina, et al.
Thrombosis and Haemostasis|July 15, 2000
In the presence of other inherited or acquired high-risk situations, the FV Cambridge mutation may be an additional thrombophilic risk factor, through its effect on APC sensitivityR Santacroce, A Bossone, V Brancaccio, et al.
Pageof 7